These authors contributed equally.
Selective inhibition by simvastatin of IRF3 phosphorylation and TSLP production in dsRNA-challenged bronchial epithelial cells from COPD donors
Version of Record online: 20 DEC 2012
© 2012 The Authors. British Journal of Pharmacology © 2012 The British Pharmacological Society
British Journal of Pharmacology
Special Issue: Themed Section: Endothelin. Guest Editors: Anthony P Davenport and Matthias Barton
Volume 168, Issue 2, pages 363–374, January 2013
How to Cite
Brandelius, A., Mahmutovic Persson, I., Calvén, J., Bjermer, L., Persson, C. G., Andersson, M. and Uller, L. (2013), Selective inhibition by simvastatin of IRF3 phosphorylation and TSLP production in dsRNA-challenged bronchial epithelial cells from COPD donors. British Journal of Pharmacology, 168: 363–374. doi: 10.1111/j.1476-5381.2012.02131.x
- Issue online: 20 DEC 2012
- Version of Record online: 20 DEC 2012
- Accepted manuscript online: 6 AUG 2012 07:34AM EST
- Manuscript Accepted: 30 JUL 2012
- Manuscript Revised: 11 JUL 2012
- Manuscript Received: 4 APR 2012
- Vinnova, Swedish Heart and Lung foundation
- Crafoord Foundation
Figure S1 Effects of BX795 on dsRNA-induced TSLP mRNA. BX795 is known to inhibit activation of IRF3 and IFN production inhibited dsRNA-induced TSLP in COPD bronchial epithelial cells (n = 3). Data are presented as median ± IQR.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.